Page last updated: 2024-08-26

4-hydroxycyclophosphamide and Leukemia P388

4-hydroxycyclophosphamide has been researched along with Leukemia P388 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Voelcker, G1
Bielicki, L; Hohorst, HJ; Voelcker, G1
Kooistra, KL; Powis, G; Rosenow, S; Van Dyke, RA1

Other Studies

3 other study(ies) available for 4-hydroxycyclophosphamide and Leukemia P388

ArticleYear
Causes and possibilities to circumvent cyclophosphamide toxicity.
    Anti-cancer drugs, 2020, Volume: 31, Issue:6

    Topics: Animals; Antineoplastic Agents, Alkylating; Cell Proliferation; Cyclophosphamide; Female; Leukemia P388; Male; Mice; Phosphoramide Mustards; Toxicity Tests

2020
Thiazolidinyl- and perhydrothiazinylphosphamidesters: toxicity and preliminary antitumour evaluation.
    Journal of cancer research and clinical oncology, 1997, Volume: 123, Issue:11-12

    Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Injections, Intraperitoneal; Leukemia P388; Male; Mast-Cell Sarcoma; Mice; Nitrogen Mustard Compounds; Prodrugs; Protein Binding; Thiazines; Thiazoles; Thiazolidines; Tissue Distribution

1997
Increased toxicity of the antitumor drug cyclophosphamide in mice in the presence of the volatile anesthetic agent halothane.
    Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:1

    Topics: Animals; Brain; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Halothane; Kidney Diseases; Lethal Dose 50; Leukemia P388; Male; Metabolic Clearance Rate; Mice; Urinary Bladder Diseases

1986